August 29, 2024
6 min read
Putting the ‘Patient’ Back in Patient Services
Putting the patient back in patient services means we do more, go deeper, and customize offerings.
UBC Insights
Insights from
UBC's Expert Voices
Featured Updates
Blog
July 16, 2026
7 min read
Why 95% Compliance Isn’t Enough: The Hidden Cost of That 4–5% Gap
A 95% compliance rate sounds strong, until you calculate what it means at 100,000 cases a year. Here's what's actually hiding in that gap, and the four questions every sponsor should ask before signing with a PV vendor.
Blog
July 14, 2026
10 min read
The Centaur Model: What the Future of Pharmacovigilance Actually Looks Like
AI isn't replacing pharmacovigilance professionals. It's changing how they work. Learn why the centaur model, where humans direct AI rather than defer to it, is emerging as the standard for regulated safety operations.
Blog
July 1, 2026
8 min read
The True Cost of Cheap PV: A Framework for Evaluating Your Options
AI savings numbers are easy to put in a proposal. What's harder to find is what happens when something goes wrong. Here's a framework for pricing in the risk that vendor pitches leave out, plus four questions worth asking before you switch.
Posts by Date
Blog
Blog
August 26, 2024
6 min read
EMA/HMA Revised Guidance on Risk Minimization Measures
UBC is the leading provider of evidence development solutions with expertise in uniting evidence and access.
Blog
August 16, 2024
4 min read
The Importance of Patient Choice
Providing the patient with choice throughout their journey empowers them to take an active role in therapy initiation and persistence.
Blog
August 5, 2024
6 min read
Navigating Launch Readiness with FDA Negotiations
REMS readiness is a key component for certain drugs launch plans - are you on top of approval timelines and milestones and IT build needs?
Blog
July 29, 2024
5 min read
ICH/FDA Draft Guidance on RWD Safety Studies Highlight Their Increased Importance
Understand the latest international opinion on the plan, design, and analysis of pharmacoepidemiological safety studies using RWD.
Blog
July 22, 2024
9 min read
Enhance Your Pharmacovigilance and Regulatory Compliance with Expert PV System Transition Management and Seamless Migration
Whether your transition includes a vendor change, acquisition, or portfolio expansion, UBC makes it easy to transition your system.
Blog
June 24, 2024
4 min read
RWD Enrichment Studies: Linking Pre- and Post-Trial Data Utilizing Tokenization
Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.
Blog
June 7, 2024
5 min read
Pharmacovigilance Tableau Data Analytics Platform: All-in-One Dashboard System for PV Metrics and KPIs
The UBC PV Tableau Data Analytics Platform provides an all-in-one dashboard system for safety Key Performance Indicators (KPIs) analysis and compliance oversight.
Blog
May 30, 2024
1 min read
Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI
UBC and Seqster talked with Chilmark Research about the power of patient-mediated electronic medical record release.
Previous
